07/12/2024
The Information from M&C decisions Evaluation of Itacitinib Impact on TNFα Levels Following Immune Effector Cell (IEC) Therapy Using PKPD Modeling and Simulation Approaches was presented at the 66th ASH annual meeting. Authors: O. Ivanova, M. Pratta, I. Azarov, K. Zhudenkov, Yu. Kosinsky, K. Peskov, X. Chen, J. Sheng.
Information on Exposure-Response Relationships for Axatilimab, a Humanized Monoclonal Antibody Targeting CSF-1R, in Patients With Chronic Graft-Versus-Host Disease was also presented here. Authors: Yang Y., Volkova V., Sokolov V., Liu X., Leon C., Kosinsky Y., Sheng J., Chen X.
The poster on exposure-response modeling of the drug axatilimab, which became part of the BLA of the drug, was presented at the largest international conference ASH: American Society of Hematology.
